Compound Detail
CHEMBL270348
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL270348 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FYEWWZOKNWKHAV-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
398.2
MW (Da)
5.67
ALogP
2
HBA
2
HBD
61.5
PSA (Ų)
0.36
QED
1
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.0
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 100.0 | nM | 7.0 | Inhibition of human recombinant mPGES1 | 18029174 |
| A549 | IC50 | = | 9800.0 | nM | 5.01 | Inhibition of IL-1-beta-stimulated PGE2 production in human A549 cells in presen... | 18029174 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18029174 | 10.1016/j.bmcl.2007.10.033 | Unchecked | 1 |
| 18029174 | 10.1016/j.bmcl.2007.10.033 | A549 | 1 |
Data from ChEMBL 36 via Core Engine